These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3977888)

  • 21. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
    Koo C; Wernette-Hammond ME; Garcia Z; Malloy MJ; Uauy R; East C; Bilheimer DW; Mahley RW; Innerarity TL
    J Clin Invest; 1988 May; 81(5):1332-40. PubMed ID: 3163347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipeptide antibody against the human low-density-lipoprotein receptor. Characterization and cross-reactivity with bovine lymphocytes.
    Agnani G; Delpierre C; Benhamamouch S; Torpier G; Cachera C; Koffigan M; Tartar A; Fruchart JC; Clavey V
    Biochem J; 1989 Nov; 263(3):753-60. PubMed ID: 2688636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding properties of high-density lipoprotein subfractions and low-density lipoproteins to rabbit hepatocytes.
    Soltys PA; Portman OW; O'Malley JP
    Biochim Biophys Acta; 1982 Nov; 713(2):300-14. PubMed ID: 6295496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a specific epitope on the extracellular domain of the LDL-receptor of Trypanosoma brucei brucei.
    Bastin P; Coppens I; Saint-Remy JM; Baudhuin P; Opperdoes FR; Courtoy PJ
    Mol Biochem Parasitol; 1994 Feb; 63(2):193-202. PubMed ID: 7516491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial expression and purification of the Fab fragment of a monoclonal antibody specific for the low-density lipoprotein receptor-binding site of human apolipoprotein E.
    Raffaï R; Vukmirica J; Weisgraber KH; Rassart E; Innerarity TL; Milne R
    Protein Expr Purif; 1999 Jun; 16(1):84-90. PubMed ID: 10336864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell association of liposomes with high fluid anionic phospholipid content is mediated specifically by LDL and its receptor, LDLr.
    Amin K; Wasan KM; Albrecht RM; Heath TD
    J Pharm Sci; 2002 May; 91(5):1233-44. PubMed ID: 11977099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins.
    Benvenga S; Cahnmann HJ; Robbins J
    Endocrinology; 1990 Nov; 127(5):2241-6. PubMed ID: 2226312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin.
    Ottnad E; Via DP; Sinn H; Friedrich E; Ziegler R; Dresel HA
    Biochem J; 1990 Feb; 265(3):689-98. PubMed ID: 2154967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro.
    De Water R; Kamps JA; Van Dijk MC; Hessels EA; Kuiper J; Kruijt JK; Van Berkel TJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):41-8. PubMed ID: 1311560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native and acetylated low density lipoprotein metabolism in proliferating and quiescent bovine endothelial cells in culture.
    Sanan DA; Strümpfer AE; van der Westhuyzen DR; Coetzee GA
    Eur J Cell Biol; 1985 Jan; 36(1):81-90. PubMed ID: 3979404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
    Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
    J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of a monoclonal 2E8 Fab antibody fragment specific for the low-density lipoprotein-receptor binding region of apolipoprotein E refined at 1.9 A.
    Trakhanov S; Parkin S; Raffaï R; Milne R; Newhouse YM; Weisgraber KH; Rupp B
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):122-8. PubMed ID: 10089402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-uptake of nascent low-density lipoproteins by HepG2 cells.
    Hara S; McCall MR; Forte TM
    Biochim Biophys Acta; 1993 Jun; 1168(2):199-204. PubMed ID: 8504155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo.
    Schiele F; Park J; Redemann N; Luippold G; Nar H
    J Mol Biol; 2014 Feb; 426(4):843-52. PubMed ID: 24252255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL).
    Friedman G; Gavish D; Vogel T; Eisenberg S
    Biochim Biophys Acta; 1990 May; 1044(1):118-26. PubMed ID: 2340301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.
    Gherardi E; Bowyer DE; Fitzsimmons C; Le Cras T; Hutchings A; Butcher G
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):1-7. PubMed ID: 1741739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells.
    Pussinen PJ; Lindner H; Glatter O; Reicher H; Kostner GM; Wintersperger A; Malle E; Sattler W
    Biochim Biophys Acta; 2000 May; 1485(2-3):129-44. PubMed ID: 10832094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding.
    Chappell DA; Fry GL; Waknitz MA; Berns JJ
    J Biol Chem; 1991 Oct; 266(29):19296-302. PubMed ID: 1918046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.